ARTICLE | Distillery Therapeutics
Neurology
July 24, 2018 4:10 PM UTC
Patient sample and mouse studies suggest a factor H-CR2 conjugate that inhibits C3d deposition could help treat stroke. In postmortem brain samples from three patients, deposition of C3d was higher in...
BCIQ Company Profiles